BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 663631 CCOc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)c1 InChI=1S/C22H25N5O3/c1-3-29-17-10-11-23-21(14-17)30-18-9-8-16(2)26(15-18)22(28)19-6-4-5-7-20(19)27-24-12-13-25-27/h4-7,10-14,16,18H,3,8-9,15H2,1-2H3/t16-,18-/m1/s1 BSXZUYJRQHGPOC-SJLPKXTDSA-N 336743 4-Ethoxy-2-{[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]oxy}pyridine::US9745284, 1 Orexin receptor type 2 Homo sapiens 20.5 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336743 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336743&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324924 384988871 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663632 CCOc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)c1 InChI=1S/C22H25N5O3/c1-3-29-17-10-11-23-21(14-17)30-18-9-8-16(2)26(15-18)22(28)19-6-4-5-7-20(19)27-24-12-13-25-27/h4-7,10-14,16,18H,3,8-9,15H2,1-2H3/t16-,18-/m1/s1 BSXZUYJRQHGPOC-SJLPKXTDSA-N 336743 4-Ethoxy-2-{[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]oxy}pyridine::US9745284, 1 Orexin/Hypocretin receptor type 1 Homo sapiens 859 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336743 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336743&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324924 384988871 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663633 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)c1 InChI=1S/C21H23N5O3/c1-15-7-8-17(29-20-13-16(28-2)9-10-22-20)14-25(15)21(27)18-5-3-4-6-19(18)26-23-11-12-24-26/h3-6,9-13,15,17H,7-8,14H2,1-2H3/t15-,17-/m1/s1 ISAMJDYFGZTWHZ-NVXWUHKLSA-N 50084395 CHEMBL3426144::US9745284, 2 Orexin receptor type 2 Homo sapiens 12.5 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50084395 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50084395&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324905 103983944 CHEMBL3426144 ZINC03194140 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663634 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)c1 InChI=1S/C21H23N5O3/c1-15-7-8-17(29-20-13-16(28-2)9-10-22-20)14-25(15)21(27)18-5-3-4-6-19(18)26-23-11-12-24-26/h3-6,9-13,15,17H,7-8,14H2,1-2H3/t15-,17-/m1/s1 ISAMJDYFGZTWHZ-NVXWUHKLSA-N 50084395 CHEMBL3426144::US9745284, 2 Orexin/Hypocretin receptor type 1 Homo sapiens 617 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50084395 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50084395&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324905 103983944 CHEMBL3426144 ZINC03194140 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663635 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)c1Br InChI=1S/C21H22BrN5O3/c1-14-7-8-15(30-20-19(22)18(29-2)9-10-23-20)13-26(14)21(28)16-5-3-4-6-17(16)27-24-11-12-25-27/h3-6,9-12,14-15H,7-8,13H2,1-2H3/t14-,15-/m1/s1 DNTQSCWLONKTPQ-HUUCEWRRSA-N 336745 3-bromo-4-methoxy-2-{[(3R,6R)-6- methyl-1-{[2-(2H-1,2,3-triazol-2-yl) phenyl]carbonyl}piperidin-3- yl]oxy}pyridine::US9745284, 3 Orexin receptor type 2 Homo sapiens 14.7 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336745 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336745&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324923 384988873 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663636 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)c1Br InChI=1S/C21H22BrN5O3/c1-14-7-8-15(30-20-19(22)18(29-2)9-10-23-20)13-26(14)21(28)16-5-3-4-6-17(16)27-24-11-12-25-27/h3-6,9-12,14-15H,7-8,13H2,1-2H3/t14-,15-/m1/s1 DNTQSCWLONKTPQ-HUUCEWRRSA-N 336745 3-bromo-4-methoxy-2-{[(3R,6R)-6- methyl-1-{[2-(2H-1,2,3-triazol-2-yl) phenyl]carbonyl}piperidin-3- yl]oxy}pyridine::US9745284, 3 Orexin/Hypocretin receptor type 1 Homo sapiens 843 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336745 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336745&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324923 384988873 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663637 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1cc(OCc2ccccc2)ccn1 InChI=1S/C27H27N5O3/c1-20-11-12-23(35-26-17-22(13-14-28-26)34-19-21-7-3-2-4-8-21)18-31(20)27(33)24-9-5-6-10-25(24)32-29-15-16-30-32/h2-10,13-17,20,23H,11-12,18-19H2,1H3/t20-,23-/m1/s1 XDCNGBPBUCSTGM-NFBKMPQASA-N 336746 4-(benzyloxy)-2-{[(3R,6R)-6- methyl-1-{[2-(2H-1,2,3-triazol-2-yl) phenyl]carbonyl}piperidin-3- yl]oxy}pyridine::US9745284, 4 Orexin receptor type 2 Homo sapiens 59.4 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336746 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336746&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324904 384988874 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663638 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1cc(OCc2ccccc2)ccn1 InChI=1S/C27H27N5O3/c1-20-11-12-23(35-26-17-22(13-14-28-26)34-19-21-7-3-2-4-8-21)18-31(20)27(33)24-9-5-6-10-25(24)32-29-15-16-30-32/h2-10,13-17,20,23H,11-12,18-19H2,1H3/t20-,23-/m1/s1 XDCNGBPBUCSTGM-NFBKMPQASA-N 336746 4-(benzyloxy)-2-{[(3R,6R)-6- methyl-1-{[2-(2H-1,2,3-triazol-2-yl) phenyl]carbonyl}piperidin-3- yl]oxy}pyridine::US9745284, 4 Orexin/Hypocretin receptor type 1 Homo sapiens 1851 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336746 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336746&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324904 384988874 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663639 CC(C)Oc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)c1 InChI=1S/C23H27N5O3/c1-16(2)30-18-10-11-24-22(14-18)31-19-9-8-17(3)27(15-19)23(29)20-6-4-5-7-21(20)28-25-12-13-26-28/h4-7,10-14,16-17,19H,8-9,15H2,1-3H3/t17-,19-/m1/s1 PIBCCHNPLPHSJH-IEBWSBKVSA-N 336747 4-(1-methylethoxy)-2-{[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]oxy}pyridine::US9745284, 5 Orexin receptor type 2 Homo sapiens 15.1 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336747 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336747&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324922 384988875 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663640 CC(C)Oc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)c1 InChI=1S/C23H27N5O3/c1-16(2)30-18-10-11-24-22(14-18)31-19-9-8-17(3)27(15-19)23(29)20-6-4-5-7-21(20)28-25-12-13-26-28/h4-7,10-14,16-17,19H,8-9,15H2,1-3H3/t17-,19-/m1/s1 PIBCCHNPLPHSJH-IEBWSBKVSA-N 336747 4-(1-methylethoxy)-2-{[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]oxy}pyridine::US9745284, 5 Orexin/Hypocretin receptor type 1 Homo sapiens 669 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336747 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336747&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324922 384988875 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663641 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cnccc2-n2nccn2)c1 InChI=1S/C20H22N6O3/c1-14-3-4-16(29-19-11-15(28-2)5-8-22-19)13-25(14)20(27)17-12-21-7-6-18(17)26-23-9-10-24-26/h5-12,14,16H,3-4,13H2,1-2H3/t14-,16-/m1/s1 YBWOLNFUDBFEPB-GDBMZVCRSA-N 336748 4-methoxy-2-{[(3R,6R)-6-methyl-1-{[4-(2H-1,2,3-triazol-2-yl)pyridin-3-yl]carbonyl}piperidin-3-yl]oxy}pyridine::US9745284, 6 Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336748 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336748&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324920 384988876 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663642 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cnccc2-n2nccn2)c1 InChI=1S/C20H22N6O3/c1-14-3-4-16(29-19-11-15(28-2)5-8-22-19)13-25(14)20(27)17-12-21-7-6-18(17)26-23-9-10-24-26/h5-12,14,16H,3-4,13H2,1-2H3/t14-,16-/m1/s1 YBWOLNFUDBFEPB-GDBMZVCRSA-N 336748 4-methoxy-2-{[(3R,6R)-6-methyl-1-{[4-(2H-1,2,3-triazol-2-yl)pyridin-3-yl]carbonyl}piperidin-3-yl]oxy}pyridine::US9745284, 6 Orexin/Hypocretin receptor type 1 Homo sapiens 2177 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336748 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336748&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324920 384988876 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663643 CC(C)Oc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2ncnn2)c1 InChI=1S/C22H26N6O3/c1-15(2)30-17-10-11-23-21(12-17)31-18-9-8-16(3)27(13-18)22(29)19-6-4-5-7-20(19)28-25-14-24-26-28/h4-7,10-12,14-16,18H,8-9,13H2,1-3H3/t16-,18-/m1/s1 OYDYWIVFNQHIRJ-SJLPKXTDSA-N 336749 4-(1- methylethoxy)- 2-{[(3R,6R)-6- methyl-1-{[2- (2H-tetrazol-2- yl)phenyl] carbonyl} piperidin-3- yl]oxy}pyridine::US9745284, 7 Orexin receptor type 2 Homo sapiens 23.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336749 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336749&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324921 384988877 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663644 CC(C)Oc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2ncnn2)c1 InChI=1S/C22H26N6O3/c1-15(2)30-17-10-11-23-21(12-17)31-18-9-8-16(3)27(13-18)22(29)19-6-4-5-7-20(19)28-25-14-24-26-28/h4-7,10-12,14-16,18H,8-9,13H2,1-3H3/t16-,18-/m1/s1 OYDYWIVFNQHIRJ-SJLPKXTDSA-N 336749 4-(1- methylethoxy)- 2-{[(3R,6R)-6- methyl-1-{[2- (2H-tetrazol-2- yl)phenyl] carbonyl} piperidin-3- yl]oxy}pyridine::US9745284, 7 Orexin/Hypocretin receptor type 1 Homo sapiens 1198 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336749 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336749&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324921 384988877 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663645 CCOc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2ncnn2)c1 InChI=1S/C21H24N6O3/c1-3-29-16-10-11-22-20(12-16)30-17-9-8-15(2)26(13-17)21(28)18-6-4-5-7-19(18)27-24-14-23-25-27/h4-7,10-12,14-15,17H,3,8-9,13H2,1-2H3/t15-,17-/m1/s1 BAGRQLSLJGYRJT-NVXWUHKLSA-N 336750 4-ethoxy-2- {[(3R,6R)-6- methyl-1-{[2- (2H-tetrazol-2- yl)phenyl] carbonyl} piperidin-3- yl]oxy}pyridine::US9745284, 8 Orexin receptor type 2 Homo sapiens 35.4 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336750 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336750&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324902 384988878 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663646 CCOc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2ncnn2)c1 InChI=1S/C21H24N6O3/c1-3-29-16-10-11-22-20(12-16)30-17-9-8-15(2)26(13-17)21(28)18-6-4-5-7-19(18)27-24-14-23-25-27/h4-7,10-12,14-15,17H,3,8-9,13H2,1-2H3/t15-,17-/m1/s1 BAGRQLSLJGYRJT-NVXWUHKLSA-N 336750 4-ethoxy-2- {[(3R,6R)-6- methyl-1-{[2- (2H-tetrazol-2- yl)phenyl] carbonyl} piperidin-3- yl]oxy}pyridine::US9745284, 8 Orexin/Hypocretin receptor type 1 Homo sapiens 2008 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336750 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336750&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324902 384988878 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663647 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cccc(F)c2-n2nccn2)c1 InChI=1S/C21H22FN5O3/c1-14-6-7-16(30-19-12-15(29-2)8-9-23-19)13-26(14)21(28)17-4-3-5-18(22)20(17)27-24-10-11-25-27/h3-5,8-12,14,16H,6-7,13H2,1-2H3/t14-,16-/m1/s1 DRBUGPOMTSOULG-GDBMZVCRSA-N 336751 2-{[(3R,6R)-1- {[3-fluoro-2-(2H- 1,2,3-triazol-2-yl) phenyl]carbonyl}- 6-methylpiperidin- 3-yl]oxy}-4- methoxypyridine::US9745284, 10 Orexin receptor type 2 Homo sapiens 14.7 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336751 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336751&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78320895 384988879 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663648 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cccc(F)c2-n2nccn2)c1 InChI=1S/C21H22FN5O3/c1-14-6-7-16(30-19-12-15(29-2)8-9-23-19)13-26(14)21(28)17-4-3-5-18(22)20(17)27-24-10-11-25-27/h3-5,8-12,14,16H,6-7,13H2,1-2H3/t14-,16-/m1/s1 DRBUGPOMTSOULG-GDBMZVCRSA-N 336751 2-{[(3R,6R)-1- {[3-fluoro-2-(2H- 1,2,3-triazol-2-yl) phenyl]carbonyl}- 6-methylpiperidin- 3-yl]oxy}-4- methoxypyridine::US9745284, 10 Orexin/Hypocretin receptor type 1 Homo sapiens 576 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336751 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336751&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78320895 384988879 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663649 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2C2CC2)c1 InChI=1S/C22H26N2O3/c1-15-7-10-18(27-21-13-17(26-2)11-12-23-21)14-24(15)22(25)20-6-4-3-5-19(20)16-8-9-16/h3-6,11-13,15-16,18H,7-10,14H2,1-2H3/t15-,18-/m1/s1 GYGMDAYVLLBIMI-CRAIPNDOSA-N 336752 2-({(3R,6R)-1-[(2- cyclopropylphenyl) carbonyl]-6- methylpiperidin- 3-yl}oxy)-4- methoxypyridine::US9745284, 12 Orexin receptor type 2 Homo sapiens 11.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336752 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336752&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78320894 384988880 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663650 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2C2CC2)c1 InChI=1S/C22H26N2O3/c1-15-7-10-18(27-21-13-17(26-2)11-12-23-21)14-24(15)22(25)20-6-4-3-5-19(20)16-8-9-16/h3-6,11-13,15-16,18H,7-10,14H2,1-2H3/t15-,18-/m1/s1 GYGMDAYVLLBIMI-CRAIPNDOSA-N 336752 2-({(3R,6R)-1-[(2- cyclopropylphenyl) carbonyl]-6- methylpiperidin- 3-yl}oxy)-4- methoxypyridine::US9745284, 12 Orexin/Hypocretin receptor type 1 Homo sapiens 938 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336752 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336752&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78320894 384988880 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663651 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2C(F)(F)F)c1 InChI=1S/C20H21F3N2O3/c1-13-7-8-15(28-18-11-14(27-2)9-10-24-18)12-25(13)19(26)16-5-3-4-6-17(16)20(21,22)23/h3-6,9-11,13,15H,7-8,12H2,1-2H3/t13-,15-/m1/s1 ODQYMONASKUWRZ-UKRRQHHQSA-N 336753 4-methoxy-2- {[(3R,6R)-6- methyl-1-{[2- (trifluoromethyl) phenyl]carbonyl} piperidin-3-yl] oxy}pyridine::US9745284, 13 Orexin receptor type 2 Homo sapiens 56.2 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336753&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324936 384988881 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663652 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2C(F)(F)F)c1 InChI=1S/C20H21F3N2O3/c1-13-7-8-15(28-18-11-14(27-2)9-10-24-18)12-25(13)19(26)16-5-3-4-6-17(16)20(21,22)23/h3-6,9-11,13,15H,7-8,12H2,1-2H3/t13-,15-/m1/s1 ODQYMONASKUWRZ-UKRRQHHQSA-N 336753 4-methoxy-2- {[(3R,6R)-6- methyl-1-{[2- (trifluoromethyl) phenyl]carbonyl} piperidin-3-yl] oxy}pyridine::US9745284, 13 Orexin/Hypocretin receptor type 1 Homo sapiens 1755 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336753&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324936 384988881 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663653 CCOc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1cc(OC)ccn1 InChI=1S/C21H26N2O4/c1-4-26-19-8-6-5-7-18(19)21(24)23-14-17(10-9-15(23)2)27-20-13-16(25-3)11-12-22-20/h5-8,11-13,15,17H,4,9-10,14H2,1-3H3/t15-,17-/m1/s1 XATLKABOKHROMI-NVXWUHKLSA-N 336754 2-({(3R,6R)-1-[(2- ethoxyphenyl) carbonyl]-6- methylpiperidin- 3-yl}oxy)-4- methoxypyridine::US9745284, 14 Orexin receptor type 2 Homo sapiens 34.8 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336754 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336754&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78320893 384988882 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663654 CCOc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)Oc1cc(OC)ccn1 InChI=1S/C21H26N2O4/c1-4-26-19-8-6-5-7-18(19)21(24)23-14-17(10-9-15(23)2)27-20-13-16(25-3)11-12-22-20/h5-8,11-13,15,17H,4,9-10,14H2,1-3H3/t15-,17-/m1/s1 XATLKABOKHROMI-NVXWUHKLSA-N 336754 2-({(3R,6R)-1-[(2- ethoxyphenyl) carbonyl]-6- methylpiperidin- 3-yl}oxy)-4- methoxypyridine::US9745284, 14 Orexin/Hypocretin receptor type 1 Homo sapiens 1981 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336754 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336754&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78320893 384988882 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663655 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(OC)nc2-c2ccccc2)c1 InChI=1S/C25H27N3O4/c1-17-9-10-20(32-23-15-19(30-2)13-14-26-23)16-28(17)25(29)21-11-12-22(31-3)27-24(21)18-7-5-4-6-8-18/h4-8,11-15,17,20H,9-10,16H2,1-3H3/t17-,20-/m1/s1 QSJUOTMTYIOYGK-YLJYHZDGSA-N 336755 6-methoxy-3- ({(2R,5R)-5-[(4- methoxypyridin- 2-yl)oxy]-2- methylpiperidin- 1-yl}carbonyl)-2- phenylpyridine::US9745284, 15 Orexin receptor type 2 Homo sapiens 24.5 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336755 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336755&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324907 384988883 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663656 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(OC)nc2-c2ccccc2)c1 InChI=1S/C25H27N3O4/c1-17-9-10-20(32-23-15-19(30-2)13-14-26-23)16-28(17)25(29)21-11-12-22(31-3)27-24(21)18-7-5-4-6-8-18/h4-8,11-15,17,20H,9-10,16H2,1-3H3/t17-,20-/m1/s1 QSJUOTMTYIOYGK-YLJYHZDGSA-N 336755 6-methoxy-3- ({(2R,5R)-5-[(4- methoxypyridin- 2-yl)oxy]-2- methylpiperidin- 1-yl}carbonyl)-2- phenylpyridine::US9745284, 15 Orexin/Hypocretin receptor type 1 Homo sapiens 746 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336755 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336755&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324907 384988883 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663657 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(F)cccc2-n2nccn2)c1 InChI=1S/C21H22FN5O3/c1-14-6-7-16(30-19-12-15(29-2)8-9-23-19)13-26(14)21(28)20-17(22)4-3-5-18(20)27-24-10-11-25-27/h3-5,8-12,14,16H,6-7,13H2,1-2H3/t14-,16-/m1/s1 PVXJZNKHROWFQX-GDBMZVCRSA-N 336756 2-{[(3R,6R)-1- {[2-fluoro-6-(2H- 1,2,3-triazol-2-yl) phenyl]carbonyl}- 6-methylpiperidin- 3-yl]oxy}-4- methoxypyridine::US9745284, 17 Orexin receptor type 2 Homo sapiens 27.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336756&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324906 384988884 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663658 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2c(F)cccc2-n2nccn2)c1 InChI=1S/C21H22FN5O3/c1-14-6-7-16(30-19-12-15(29-2)8-9-23-19)13-26(14)21(28)20-17(22)4-3-5-18(20)27-24-10-11-25-27/h3-5,8-12,14,16H,6-7,13H2,1-2H3/t14-,16-/m1/s1 PVXJZNKHROWFQX-GDBMZVCRSA-N 336756 2-{[(3R,6R)-1- {[2-fluoro-6-(2H- 1,2,3-triazol-2-yl) phenyl]carbonyl}- 6-methylpiperidin- 3-yl]oxy}-4- methoxypyridine::US9745284, 17 Orexin/Hypocretin receptor type 1 Homo sapiens 1605 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336756&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324906 384988884 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663659 COc1ccc(C(=O)N2C[C@@H](CC[C@H]2C)Oc2cc(OC(C)C)ccn2)c(n1)-n1nccn1 InChI=1S/C23H28N6O4/c1-15(2)32-17-9-10-24-21(13-17)33-18-6-5-16(3)28(14-18)23(30)19-7-8-20(31-4)27-22(19)29-25-11-12-26-29/h7-13,15-16,18H,5-6,14H2,1-4H3/t16-,18-/m1/s1 GYTOSHJIIYYSNO-SJLPKXTDSA-N 336757 6-methoxy-3- ({(2R,5R)-5-[(4- methoxypyridin- 2-yl)oxy]-2- methylpyridin-1- yl}carbonyl)-2- (2H-1,2,3-triazol- 2-yl)pyridine::US9745284, 18::US9745284, 25 Orexin receptor type 2 Homo sapiens 94.5 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336757&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324938 384988885 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663660 COc1ccc(C(=O)N2C[C@@H](CC[C@H]2C)Oc2cc(OC(C)C)ccn2)c(n1)-n1nccn1 InChI=1S/C23H28N6O4/c1-15(2)32-17-9-10-24-21(13-17)33-18-6-5-16(3)28(14-18)23(30)19-7-8-20(31-4)27-22(19)29-25-11-12-26-29/h7-13,15-16,18H,5-6,14H2,1-4H3/t16-,18-/m1/s1 GYTOSHJIIYYSNO-SJLPKXTDSA-N 336757 6-methoxy-3- ({(2R,5R)-5-[(4- methoxypyridin- 2-yl)oxy]-2- methylpyridin-1- yl}carbonyl)-2- (2H-1,2,3-triazol- 2-yl)pyridine::US9745284, 18::US9745284, 25 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336757&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324938 384988885 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663661 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-n2nccn2)c1 InChI=1S/C21H22FN5O3/c1-14-3-5-17(30-20-12-16(29-2)7-8-23-20)13-26(14)21(28)18-6-4-15(22)11-19(18)27-24-9-10-25-27/h4,6-12,14,17H,3,5,13H2,1-2H3/t14-,17-/m1/s1 LOFWBVNSZHSGNN-RHSMWYFYSA-N 336758 2-{[(3R,6R)-1- {[4-fluoro-2-(2H- 1,2,3-triazol-2-yl) phenyl]carbonyl}- 6-methylpiperidin- 3-yl]oxy}-4- methoxypyridine::US9745284, 19 Orexin receptor type 2 Homo sapiens 22.1 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336758 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336758&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78320572 384988886 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663662 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-n2nccn2)c1 InChI=1S/C21H22FN5O3/c1-14-3-5-17(30-20-12-16(29-2)7-8-23-20)13-26(14)21(28)18-6-4-15(22)11-19(18)27-24-9-10-25-27/h4,6-12,14,17H,3,5,13H2,1-2H3/t14-,17-/m1/s1 LOFWBVNSZHSGNN-RHSMWYFYSA-N 336758 2-{[(3R,6R)-1- {[4-fluoro-2-(2H- 1,2,3-triazol-2-yl) phenyl]carbonyl}- 6-methylpiperidin- 3-yl]oxy}-4- methoxypyridine::US9745284, 19 Orexin/Hypocretin receptor type 1 Homo sapiens 1800 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336758 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336758&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78320572 384988886 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663663 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(OC)cc2-n2nccn2)c1 InChI=1S/C22H25N5O4/c1-15-4-5-18(31-21-13-17(30-3)8-9-23-21)14-26(15)22(28)19-7-6-16(29-2)12-20(19)27-24-10-11-25-27/h6-13,15,18H,4-5,14H2,1-3H3/t15-,18-/m1/s1 LWYIDQYFRXCNMR-CRAIPNDOSA-N 336759 4-methoxy-2- {[(3R,6R)-1-{[4- methoxy-2-(2H- 1,2,3-triazol-2-yl) phenyl]carbonyl}- 6-methylpiperidin- 3-yl]oxy}pyridine::US9745284, 20 Orexin receptor type 2 Homo sapiens 114 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336759 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336759&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78320890 384988887 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663664 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(OC)cc2-n2nccn2)c1 InChI=1S/C22H25N5O4/c1-15-4-5-18(31-21-13-17(30-3)8-9-23-21)14-26(15)22(28)19-7-6-16(29-2)12-20(19)27-24-10-11-25-27/h6-13,15,18H,4-5,14H2,1-3H3/t15-,18-/m1/s1 LWYIDQYFRXCNMR-CRAIPNDOSA-N 336759 4-methoxy-2- {[(3R,6R)-1-{[4- methoxy-2-(2H- 1,2,3-triazol-2-yl) phenyl]carbonyl}- 6-methylpiperidin- 3-yl]oxy}pyridine::US9745284, 20 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336759 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336759&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78320890 384988887 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663665 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(OC)nc2C2CC2)c1 InChI=1S/C22H27N3O4/c1-14-4-7-17(29-20-12-16(27-2)10-11-23-20)13-25(14)22(26)18-8-9-19(28-3)24-21(18)15-5-6-15/h8-12,14-15,17H,4-7,13H2,1-3H3/t14-,17-/m1/s1 ZUJOAJUYYMEPLK-RHSMWYFYSA-N 336760 2-cyclopropyl- 6-methoxy-3- ({(2R,5R)-5-[(4- methoxypyridin- 2-yl)oxy]-2- methylpiperidin-1- yl}carbonyl) pyridine::US9745284, 21 Orexin receptor type 2 Homo sapiens 38.3 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336760 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336760&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324956 384988888 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663666 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(OC)nc2C2CC2)c1 InChI=1S/C22H27N3O4/c1-14-4-7-17(29-20-12-16(27-2)10-11-23-20)13-25(14)22(26)18-8-9-19(28-3)24-21(18)15-5-6-15/h8-12,14-15,17H,4-7,13H2,1-3H3/t14-,17-/m1/s1 ZUJOAJUYYMEPLK-RHSMWYFYSA-N 336760 2-cyclopropyl- 6-methoxy-3- ({(2R,5R)-5-[(4- methoxypyridin- 2-yl)oxy]-2- methylpiperidin-1- yl}carbonyl) pyridine::US9745284, 21 Orexin/Hypocretin receptor type 1 Homo sapiens 8194 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336760 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336760&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324956 384988888 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663667 CC(C)Oc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-n2nccn2)c1 InChI=1S/C23H26FN5O3/c1-15(2)31-18-8-9-25-22(13-18)32-19-6-4-16(3)28(14-19)23(30)20-7-5-17(24)12-21(20)29-26-10-11-27-29/h5,7-13,15-16,19H,4,6,14H2,1-3H3/t16-,19-/m1/s1 NEZYDUOOYRFBSZ-VQIMIIECSA-N 336761 2-{[(3R,6R)-1- {[4-fluoro-2-(2H- 1,2,3-triazol-2-yl) phenyl]carbonyl}- 6-methylpiperidin- 3-yl]oxy}-4-(1- methylethoxy) pyridine::US9745284, 23 Orexin receptor type 2 Homo sapiens 41.2 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336761 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336761&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324957 384988889 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663668 CC(C)Oc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccc(F)cc2-n2nccn2)c1 InChI=1S/C23H26FN5O3/c1-15(2)31-18-8-9-25-22(13-18)32-19-6-4-16(3)28(14-19)23(30)20-7-5-17(24)12-21(20)29-26-10-11-27-29/h5,7-13,15-16,19H,4,6,14H2,1-3H3/t16-,19-/m1/s1 NEZYDUOOYRFBSZ-VQIMIIECSA-N 336761 2-{[(3R,6R)-1- {[4-fluoro-2-(2H- 1,2,3-triazol-2-yl) phenyl]carbonyl}- 6-methylpiperidin- 3-yl]oxy}-4-(1- methylethoxy) pyridine::US9745284, 23 Orexin/Hypocretin receptor type 1 Homo sapiens 2145 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336761 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336761&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324957 384988889 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663669 COc1ccc(C(=O)N2C[C@@H](CC[C@H]2C)Oc2cc(OC(C)C)ccn2)c(c1)-n1nccn1 InChI=1S/C24H29N5O4/c1-16(2)32-19-9-10-25-23(14-19)33-20-6-5-17(3)28(15-20)24(30)21-8-7-18(31-4)13-22(21)29-26-11-12-27-29/h7-14,16-17,20H,5-6,15H2,1-4H3/t17-,20-/m1/s1 NESDAUREAOYUGI-YLJYHZDGSA-N 336762 2-{[(3R,6R)-1- {[4-methoxy-2- (2H-1,2,3-triazol- 2-yl)phenyl] carbonyl}-6- methylpiperidin- 3-yl]oxy}-4-(1- methylethoxy) pyridine::US9745284, 24 Orexin receptor type 2 Homo sapiens 136 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336762&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324955 384988890 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663670 COc1ccc(C(=O)N2C[C@@H](CC[C@H]2C)Oc2cc(OC(C)C)ccn2)c(c1)-n1nccn1 InChI=1S/C24H29N5O4/c1-16(2)32-19-9-10-25-23(14-19)33-20-6-5-17(3)28(15-20)24(30)21-8-7-18(31-4)13-22(21)29-26-11-12-27-29/h7-14,16-17,20H,5-6,15H2,1-4H3/t17-,20-/m1/s1 NESDAUREAOYUGI-YLJYHZDGSA-N 336762 2-{[(3R,6R)-1- {[4-methoxy-2- (2H-1,2,3-triazol- 2-yl)phenyl] carbonyl}-6- methylpiperidin- 3-yl]oxy}-4-(1- methylethoxy) pyridine::US9745284, 24 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336762&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324955 384988890 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663671 COc1ccc(C(=O)N2C[C@@H](CC[C@H]2C)Oc2cc(OC(C)C)ccn2)c(n1)-n1nccn1 InChI=1S/C23H28N6O4/c1-15(2)32-17-9-10-24-21(13-17)33-18-6-5-16(3)28(14-18)23(30)19-7-8-20(31-4)27-22(19)29-25-11-12-26-29/h7-13,15-16,18H,5-6,14H2,1-4H3/t16-,18-/m1/s1 GYTOSHJIIYYSNO-SJLPKXTDSA-N 336757 6-methoxy-3- ({(2R,5R)-5-[(4- methoxypyridin- 2-yl)oxy]-2- methylpyridin-1- yl}carbonyl)-2- (2H-1,2,3-triazol- 2-yl)pyridine::US9745284, 18::US9745284, 25 Orexin receptor type 2 Homo sapiens 110 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336757&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324938 384988885 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663672 COc1ccc(C(=O)N2C[C@@H](CC[C@H]2C)Oc2cc(OC(C)C)ccn2)c(n1)-n1nccn1 InChI=1S/C23H28N6O4/c1-15(2)32-17-9-10-24-21(13-17)33-18-6-5-16(3)28(14-18)23(30)19-7-8-20(31-4)27-22(19)29-25-11-12-26-29/h7-13,15-16,18H,5-6,14H2,1-4H3/t16-,18-/m1/s1 GYTOSHJIIYYSNO-SJLPKXTDSA-N 336757 6-methoxy-3- ({(2R,5R)-5-[(4- methoxypyridin- 2-yl)oxy]-2- methylpyridin-1- yl}carbonyl)-2- (2H-1,2,3-triazol- 2-yl)pyridine::US9745284, 18::US9745284, 25 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336757&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324938 384988885 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663673 CC(C)Oc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(F)ccc2-n2nccn2)c1 InChI=1S/C23H26FN5O3/c1-15(2)31-18-8-9-25-22(13-18)32-19-6-4-16(3)28(14-19)23(30)20-12-17(24)5-7-21(20)29-26-10-11-27-29/h5,7-13,15-16,19H,4,6,14H2,1-3H3/t16-,19-/m1/s1 AOWRXBPHHNTVMX-VQIMIIECSA-N 336764 2-{[(3R,6R)-1- {[5-fluoro-2-(2H- 1,2,3-triazol-2-yl) phenyl]carbonyl}- 6-methylpiperidin- 3-yl]oxy}-4-(1- methylethoxy) pyridine::US9745284, 26 Orexin receptor type 2 Homo sapiens 37.2 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336764 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336764&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324953 384988891 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663674 CC(C)Oc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2cc(F)ccc2-n2nccn2)c1 InChI=1S/C23H26FN5O3/c1-15(2)31-18-8-9-25-22(13-18)32-19-6-4-16(3)28(14-19)23(30)20-12-17(24)5-7-21(20)29-26-10-11-27-29/h5,7-13,15-16,19H,4,6,14H2,1-3H3/t16-,19-/m1/s1 AOWRXBPHHNTVMX-VQIMIIECSA-N 336764 2-{[(3R,6R)-1- {[5-fluoro-2-(2H- 1,2,3-triazol-2-yl) phenyl]carbonyl}- 6-methylpiperidin- 3-yl]oxy}-4-(1- methylethoxy) pyridine::US9745284, 26 Orexin/Hypocretin receptor type 1 Homo sapiens 2479 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336764 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336764&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324953 384988891 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663675 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C22H23F2N5O3/c1-15-6-7-17(32-21-12-16(8-9-25-21)31-14-20(23)24)13-28(15)22(30)18-4-2-3-5-19(18)29-26-10-11-27-29/h2-5,8-12,15,17,20H,6-7,13-14H2,1H3/t15-,17-/m1/s1 PJJPRQDWGCCETP-NVXWUHKLSA-N 336765 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((4-(2,2-difluoroethoxy)pyridin-2-yl)oxy)-2-methylpiperidin-1-yl)methanone::US9745284, 27 Orexin receptor type 2 Homo sapiens 12.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336765 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336765&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324952 384988892 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663676 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C22H23F2N5O3/c1-15-6-7-17(32-21-12-16(8-9-25-21)31-14-20(23)24)13-28(15)22(30)18-4-2-3-5-19(18)29-26-10-11-27-29/h2-5,8-12,15,17,20H,6-7,13-14H2,1H3/t15-,17-/m1/s1 PJJPRQDWGCCETP-NVXWUHKLSA-N 336765 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((4-(2,2-difluoroethoxy)pyridin-2-yl)oxy)-2-methylpiperidin-1-yl)methanone::US9745284, 27 Orexin/Hypocretin receptor type 1 Homo sapiens 1418 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336765 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336765&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324952 384988892 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663677 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1cc(OCC(F)(F)F)ccn1 InChI=1S/C22H22F3N5O3/c1-15-6-7-17(33-20-12-16(8-9-26-20)32-14-22(23,24)25)13-29(15)21(31)18-4-2-3-5-19(18)30-27-10-11-28-30/h2-5,8-12,15,17H,6-7,13-14H2,1H3/t15-,17-/m1/s1 BHNGYFMOFFKONB-NVXWUHKLSA-N 336766 (2-(2H-1,2,3-triazol-2- yl)phenyl)((2R,5R)-2- methyl-5-((4-(2,2,2- trifluoroethoxy)pyridin-2- yl)oxy)piperidin-1- yl)methanone::US9745284, 28 Orexin receptor type 2 Homo sapiens 8.00 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336766&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324941 384988893 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663678 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1cc(OCC(F)(F)F)ccn1 InChI=1S/C22H22F3N5O3/c1-15-6-7-17(33-20-12-16(8-9-26-20)32-14-22(23,24)25)13-29(15)21(31)18-4-2-3-5-19(18)30-27-10-11-28-30/h2-5,8-12,15,17H,6-7,13-14H2,1H3/t15-,17-/m1/s1 BHNGYFMOFFKONB-NVXWUHKLSA-N 336766 (2-(2H-1,2,3-triazol-2- yl)phenyl)((2R,5R)-2- methyl-5-((4-(2,2,2- trifluoroethoxy)pyridin-2- yl)oxy)piperidin-1- yl)methanone::US9745284, 28 Orexin/Hypocretin receptor type 1 Homo sapiens 1345 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336766&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324941 384988893 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663679 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C21H22F2N6O3/c1-14-6-7-16(32-20-10-15(8-9-24-20)31-12-19(22)23)11-28(14)21(30)17-4-2-3-5-18(17)29-26-13-25-27-29/h2-5,8-10,13-14,16,19H,6-7,11-12H2,1H3/t14-,16-/m1/s1 YIZRZQRHASXKNC-GDBMZVCRSA-N 336767 4-(2,2-difluoroethoxy)-2- {[(3R,6R)-6-methyl-1-{[2- (2H-tetrazol-2- yl)phenyl]carbonyl}piperidin- 3-yl]oxy}pyridine::US9745284, 29 Orexin receptor type 2 Homo sapiens 29.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336767 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336767&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324969 384988894 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663680 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C21H22F2N6O3/c1-14-6-7-16(32-20-10-15(8-9-24-20)31-12-19(22)23)11-28(14)21(30)17-4-2-3-5-18(17)29-26-13-25-27-29/h2-5,8-10,13-14,16,19H,6-7,11-12H2,1H3/t14-,16-/m1/s1 YIZRZQRHASXKNC-GDBMZVCRSA-N 336767 4-(2,2-difluoroethoxy)-2- {[(3R,6R)-6-methyl-1-{[2- (2H-tetrazol-2- yl)phenyl]carbonyl}piperidin- 3-yl]oxy}pyridine::US9745284, 29 Orexin/Hypocretin receptor type 1 Homo sapiens 8074 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336767 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336767&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324969 384988894 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663681 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)Oc1cc(OCC(F)(F)F)ccn1 InChI=1S/C21H21F3N6O3/c1-14-6-7-16(33-19-10-15(8-9-25-19)32-12-21(22,23)24)11-29(14)20(31)17-4-2-3-5-18(17)30-27-13-26-28-30/h2-5,8-10,13-14,16H,6-7,11-12H2,1H3/t14-,16-/m1/s1 SSBIWSQHJHIUKM-GDBMZVCRSA-N 336768 2-{[(3R,6R)-6-methyl-1-{[2- (2H-tetrazol-2- yl)phenyl]carbonyl}piperidin- 3-yl]oxy}-4-(2,2,2- trifluoroethoxy)pyridine::US9745284, 30 Orexin receptor type 2 Homo sapiens 38.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336768 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336768&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324940 384988895 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663682 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)Oc1cc(OCC(F)(F)F)ccn1 InChI=1S/C21H21F3N6O3/c1-14-6-7-16(33-19-10-15(8-9-25-19)32-12-21(22,23)24)11-29(14)20(31)17-4-2-3-5-18(17)30-27-13-26-28-30/h2-5,8-10,13-14,16H,6-7,11-12H2,1H3/t14-,16-/m1/s1 SSBIWSQHJHIUKM-GDBMZVCRSA-N 336768 2-{[(3R,6R)-6-methyl-1-{[2- (2H-tetrazol-2- yl)phenyl]carbonyl}piperidin- 3-yl]oxy}-4-(2,2,2- trifluoroethoxy)pyridine::US9745284, 30 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336768 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336768&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324940 384988895 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663683 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1CS(C)(=O)=O)Oc1cc(OCC(F)F)ccn1 InChI=1S/C22H26F2N2O5S/c1-15-7-8-18(31-21-11-17(9-10-25-21)30-13-20(23)24)12-26(15)22(27)19-6-4-3-5-16(19)14-32(2,28)29/h3-6,9-11,15,18,20H,7-8,12-14H2,1-2H3/t15-,18-/m1/s1 BJJJFGUBVXIICD-CRAIPNDOSA-N 336769 4-(2,2-difluoroethoxy)-2- {[(3R,6R)-6-methyl-1-({2- [(methylsulfonyl)methyl] phenyl}carbonyl)piperidin-3- yl]oxy}pyridine::US9745284, 31 Orexin receptor type 2 Homo sapiens 34.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336769 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336769&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324939 384988896 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663684 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1CS(C)(=O)=O)Oc1cc(OCC(F)F)ccn1 InChI=1S/C22H26F2N2O5S/c1-15-7-8-18(31-21-11-17(9-10-25-21)30-13-20(23)24)12-26(15)22(27)19-6-4-3-5-16(19)14-32(2,28)29/h3-6,9-11,15,18,20H,7-8,12-14H2,1-2H3/t15-,18-/m1/s1 BJJJFGUBVXIICD-CRAIPNDOSA-N 336769 4-(2,2-difluoroethoxy)-2- {[(3R,6R)-6-methyl-1-({2- [(methylsulfonyl)methyl] phenyl}carbonyl)piperidin-3- yl]oxy}pyridine::US9745284, 31 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336769 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336769&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324939 384988896 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663685 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)Oc1cc(OCC(F)F)ccn1 InChI=1S/C24H25F2N3O3/c1-16-6-7-18(32-22-12-17(8-11-28-22)31-14-21(25)26)13-29(16)23(30)19-4-2-3-5-20(19)24(15-27)9-10-24/h2-5,8,11-12,16,18,21H,6-7,9-10,13-14H2,1H3/t16-,18-/m1/s1 MYTDUKXKEBTHDJ-SJLPKXTDSA-N 336770 1-(2-{[(2R,5R)-5-{[4-(2,2- difluoroethoxy)pyridin-2- yl]oxy}-2-methylpiperidin-1- yl]carbonyl}phenyl) cyclopropanecarbonitrile::US9745284, 32 Orexin receptor type 2 Homo sapiens 24.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336770 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336770&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324937 384988897 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663686 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)Oc1cc(OCC(F)F)ccn1 InChI=1S/C24H25F2N3O3/c1-16-6-7-18(32-22-12-17(8-11-28-22)31-14-21(25)26)13-29(16)23(30)19-4-2-3-5-20(19)24(15-27)9-10-24/h2-5,8,11-12,16,18,21H,6-7,9-10,13-14H2,1H3/t16-,18-/m1/s1 MYTDUKXKEBTHDJ-SJLPKXTDSA-N 336770 1-(2-{[(2R,5R)-5-{[4-(2,2- difluoroethoxy)pyridin-2- yl]oxy}-2-methylpiperidin-1- yl]carbonyl}phenyl) cyclopropanecarbonitrile::US9745284, 32 Orexin/Hypocretin receptor type 1 Homo sapiens 4355 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336770 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336770&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324937 384988897 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663687 C[C@@H]1CC[C@H](CN1C(=O)c1ncccc1-n1nccn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C21H22F2N6O3/c1-14-4-5-16(32-19-11-15(6-8-24-19)31-13-18(22)23)12-28(14)21(30)20-17(3-2-7-25-20)29-26-9-10-27-29/h2-3,6-11,14,16,18H,4-5,12-13H2,1H3/t14-,16-/m1/s1 OGZGPRBWSZBKCM-GDBMZVCRSA-N 336771 2-{[(2R,5R)-5-{[4-(2,2- difluoroethoxy)pyridin-2- yl]oxy}-2-methylpiperidin-1- yl]carbonyl}-3-(2H-1,2,3- triazol-2-yl)pyridine::US9745284, 33 Orexin receptor type 2 Homo sapiens 71.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336771 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336771&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78325010 384988898 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663688 C[C@@H]1CC[C@H](CN1C(=O)c1ncccc1-n1nccn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C21H22F2N6O3/c1-14-4-5-16(32-19-11-15(6-8-24-19)31-13-18(22)23)12-28(14)21(30)20-17(3-2-7-25-20)29-26-9-10-27-29/h2-3,6-11,14,16,18H,4-5,12-13H2,1H3/t14-,16-/m1/s1 OGZGPRBWSZBKCM-GDBMZVCRSA-N 336771 2-{[(2R,5R)-5-{[4-(2,2- difluoroethoxy)pyridin-2- yl]oxy}-2-methylpiperidin-1- yl]carbonyl}-3-(2H-1,2,3- triazol-2-yl)pyridine::US9745284, 33 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336771 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336771&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78325010 384988898 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663689 C[C@@H]1CC[C@H](CN1C(=O)c1cccc(F)c1-n1nccn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C22H22F3N5O3/c1-14-5-6-16(33-20-11-15(7-8-26-20)32-13-19(24)25)12-29(14)22(31)17-3-2-4-18(23)21(17)30-27-9-10-28-30/h2-4,7-11,14,16,19H,5-6,12-13H2,1H3/t14-,16-/m1/s1 VBAUBZFUSAQVDY-GDBMZVCRSA-N 336772 4-(2,2-difluoroethoxy)-2- {[(3R,6R)-1-{[3-fluoro-2- (2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3- yl]oxy}pyridine::US9745284, 34 Orexin receptor type 2 Homo sapiens 42.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336772 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336772&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78325000 384988899 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663690 C[C@@H]1CC[C@H](CN1C(=O)c1cccc(F)c1-n1nccn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C22H22F3N5O3/c1-14-5-6-16(33-20-11-15(7-8-26-20)32-13-19(24)25)12-29(14)22(31)17-3-2-4-18(23)21(17)30-27-9-10-28-30/h2-4,7-11,14,16,19H,5-6,12-13H2,1H3/t14-,16-/m1/s1 VBAUBZFUSAQVDY-GDBMZVCRSA-N 336772 4-(2,2-difluoroethoxy)-2- {[(3R,6R)-1-{[3-fluoro-2- (2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3- yl]oxy}pyridine::US9745284, 34 Orexin/Hypocretin receptor type 1 Homo sapiens 2142 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336772 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336772&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78325000 384988899 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663691 C[C@@H]1CC[C@H](CN1C(=O)c1ccc(F)cc1-n1nccn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C22H22F3N5O3/c1-14-2-4-17(33-21-11-16(6-7-26-21)32-13-20(24)25)12-29(14)22(31)18-5-3-15(23)10-19(18)30-27-8-9-28-30/h3,5-11,14,17,20H,2,4,12-13H2,1H3/t14-,17-/m1/s1 WLMXJRSPEBHERE-RHSMWYFYSA-N 336773 4-(2,2-difluoroethoxy)-2- {[(3R,6R)-1-{[4-fluoro-2- (2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3- yl]oxy}pyridine::US9745284, 35 Orexin receptor type 2 Homo sapiens 62.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336773 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336773&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324989 384988900 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663692 C[C@@H]1CC[C@H](CN1C(=O)c1ccc(F)cc1-n1nccn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C22H22F3N5O3/c1-14-2-4-17(33-21-11-16(6-7-26-21)32-13-20(24)25)12-29(14)22(31)18-5-3-15(23)10-19(18)30-27-8-9-28-30/h3,5-11,14,17,20H,2,4,12-13H2,1H3/t14-,17-/m1/s1 WLMXJRSPEBHERE-RHSMWYFYSA-N 336773 4-(2,2-difluoroethoxy)-2- {[(3R,6R)-1-{[4-fluoro-2- (2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3- yl]oxy}pyridine::US9745284, 35 Orexin/Hypocretin receptor type 1 Homo sapiens 3269 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336773 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336773&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324989 384988900 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663693 C[C@@H]1CC[C@H](CN1C(=O)c1c(F)cccc1-n1nccn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C22H22F3N5O3/c1-14-5-6-16(33-20-11-15(7-8-26-20)32-13-19(24)25)12-29(14)22(31)21-17(23)3-2-4-18(21)30-27-9-10-28-30/h2-4,7-11,14,16,19H,5-6,12-13H2,1H3/t14-,16-/m1/s1 UFABGEFXBHFAQB-GDBMZVCRSA-N 336774 4-(2,2-difluoroethoxy)-2- {[(3R,6R)-1-{[2-fluoro-6- (2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3- yl]oxy}pyridine::US9745284, 36 Orexin receptor type 2 Homo sapiens 56.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336774 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336774&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324999 384988901 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663694 C[C@@H]1CC[C@H](CN1C(=O)c1c(F)cccc1-n1nccn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C22H22F3N5O3/c1-14-5-6-16(33-20-11-15(7-8-26-20)32-13-19(24)25)12-29(14)22(31)21-17(23)3-2-4-18(21)30-27-9-10-28-30/h2-4,7-11,14,16,19H,5-6,12-13H2,1H3/t14-,16-/m1/s1 UFABGEFXBHFAQB-GDBMZVCRSA-N 336774 4-(2,2-difluoroethoxy)-2- {[(3R,6R)-1-{[2-fluoro-6- (2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3- yl]oxy}pyridine::US9745284, 36 Orexin/Hypocretin receptor type 1 Homo sapiens 2973 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336774 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336774&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324999 384988901 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663695 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1nc(C)no1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C23H24F2N4O4/c1-14-7-8-17(32-21-11-16(9-10-26-21)31-13-20(24)25)12-29(14)23(30)19-6-4-3-5-18(19)22-27-15(2)28-33-22/h3-6,9-11,14,17,20H,7-8,12-13H2,1-2H3/t14-,17-/m1/s1 LGYMRVULHQVVPL-RHSMWYFYSA-N 336775 4-(2,2-difluoroethoxy)-2- {[(3R,6R)-6-methyl-1-{[2- (3-methyl-1,2,4-oxadiazol-5- yl)phenyl]carbonyl}piperidin- 3-yl]oxy}pyridine::US9745284, 37 Orexin receptor type 2 Homo sapiens 52.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336775 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336775&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324998 384988902 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663696 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1nc(C)no1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C23H24F2N4O4/c1-14-7-8-17(32-21-11-16(9-10-26-21)31-13-20(24)25)12-29(14)23(30)19-6-4-3-5-18(19)22-27-15(2)28-33-22/h3-6,9-11,14,17,20H,7-8,12-13H2,1-2H3/t14-,17-/m1/s1 LGYMRVULHQVVPL-RHSMWYFYSA-N 336775 4-(2,2-difluoroethoxy)-2- {[(3R,6R)-6-methyl-1-{[2- (3-methyl-1,2,4-oxadiazol-5- yl)phenyl]carbonyl}piperidin- 3-yl]oxy}pyridine::US9745284, 37 Orexin/Hypocretin receptor type 1 Homo sapiens 2722 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336775 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336775&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324998 384988902 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663697 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1noc(C)n1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C23H24F2N4O4/c1-14-7-8-17(32-21-11-16(9-10-26-21)31-13-20(24)25)12-29(14)23(30)19-6-4-3-5-18(19)22-27-15(2)33-28-22/h3-6,9-11,14,17,20H,7-8,12-13H2,1-2H3/t14-,17-/m1/s1 OMBSEAHYCKDTMZ-RHSMWYFYSA-N 336776 4-(2,2-difluoroethoxy)-2- {[(3R,6R)-6-methyl-1-{[2- (5-methyl-1,2,4-oxadiazol-3- yl)phenyl]carbonyl}piperidin- 3-yl]oxy}pyridine::US9745284, 38 Orexin receptor type 2 Homo sapiens 56.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336776 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336776&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324987 384988903 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663698 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1noc(C)n1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C23H24F2N4O4/c1-14-7-8-17(32-21-11-16(9-10-26-21)31-13-20(24)25)12-29(14)23(30)19-6-4-3-5-18(19)22-27-15(2)33-28-22/h3-6,9-11,14,17,20H,7-8,12-13H2,1-2H3/t14-,17-/m1/s1 OMBSEAHYCKDTMZ-RHSMWYFYSA-N 336776 4-(2,2-difluoroethoxy)-2- {[(3R,6R)-6-methyl-1-{[2- (5-methyl-1,2,4-oxadiazol-3- yl)phenyl]carbonyl}piperidin- 3-yl]oxy}pyridine::US9745284, 38 Orexin/Hypocretin receptor type 1 Homo sapiens 2502 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336776 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336776&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324987 384988903 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663699 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1cc(OC2CC2)ccn1 InChI=1S/C23H25N5O3/c1-16-6-7-19(31-22-14-18(10-11-24-22)30-17-8-9-17)15-27(16)23(29)20-4-2-3-5-21(20)28-25-12-13-26-28/h2-5,10-14,16-17,19H,6-9,15H2,1H3/t16-,19-/m1/s1 LEJXFYNUYWDQDY-VQIMIIECSA-N 336777 4-(Cyclopropyloxy)-2-{[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-piperidin-3-yl]oxy}pyridine::US9745284, 40 Orexin receptor type 2 Homo sapiens 15.2 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336777&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78325029 384988904 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663700 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1cc(OC2CC2)ccn1 InChI=1S/C23H25N5O3/c1-16-6-7-19(31-22-14-18(10-11-24-22)30-17-8-9-17)15-27(16)23(29)20-4-2-3-5-21(20)28-25-12-13-26-28/h2-5,10-14,16-17,19H,6-9,15H2,1H3/t16-,19-/m1/s1 LEJXFYNUYWDQDY-VQIMIIECSA-N 336777 4-(Cyclopropyloxy)-2-{[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-piperidin-3-yl]oxy}pyridine::US9745284, 40 Orexin/Hypocretin receptor type 1 Homo sapiens 581 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336777&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78325029 384988904 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663701 CC(C)COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)c1 InChI=1S/C24H29N5O3/c1-17(2)16-31-19-10-11-25-23(14-19)32-20-9-8-18(3)28(15-20)24(30)21-6-4-5-7-22(21)29-26-12-13-27-29/h4-7,10-14,17-18,20H,8-9,15-16H2,1-3H3/t18-,20-/m1/s1 SPJKAZUUQZUCHC-UYAOXDASSA-N 336778 4-(2-methylpropoxy)-2-{[(3R,6R)-6- methyl-1-{[2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine::US9745284, 42 Orexin receptor type 2 Homo sapiens 134 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336778 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336778&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324988 384988905 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663702 CC(C)COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)c1 InChI=1S/C24H29N5O3/c1-17(2)16-31-19-10-11-25-23(14-19)32-20-9-8-18(3)28(15-20)24(30)21-6-4-5-7-22(21)29-26-12-13-27-29/h4-7,10-14,17-18,20H,8-9,15-16H2,1-3H3/t18-,20-/m1/s1 SPJKAZUUQZUCHC-UYAOXDASSA-N 336778 4-(2-methylpropoxy)-2-{[(3R,6R)-6- methyl-1-{[2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]oxy}pyridine::US9745284, 42 Orexin/Hypocretin receptor type 1 Homo sapiens 5611 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336778 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336778&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324988 384988905 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663703 CCCOc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)c1 InChI=1S/C23H27N5O3/c1-3-14-30-18-10-11-24-22(15-18)31-19-9-8-17(2)27(16-19)23(29)20-6-4-5-7-21(20)28-25-12-13-26-28/h4-7,10-13,15,17,19H,3,8-9,14,16H2,1-2H3/t17-,19-/m1/s1 DEKCVGRQTPIWDY-IEBWSBKVSA-N 336779 2-{[(3R,6R)-6-methyl-1-{[2-(2H- 1,2,3-triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]oxy}-4-propoxypyridine::US9745284, 43 Orexin receptor type 2 Homo sapiens 38.7 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336779&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324985 384988906 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663704 CCCOc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)c1 InChI=1S/C23H27N5O3/c1-3-14-30-18-10-11-24-22(15-18)31-19-9-8-17(2)27(16-19)23(29)20-6-4-5-7-21(20)28-25-12-13-26-28/h4-7,10-13,15,17,19H,3,8-9,14,16H2,1-2H3/t17-,19-/m1/s1 DEKCVGRQTPIWDY-IEBWSBKVSA-N 336779 2-{[(3R,6R)-6-methyl-1-{[2-(2H- 1,2,3-triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]oxy}-4-propoxypyridine::US9745284, 43 Orexin/Hypocretin receptor type 1 Homo sapiens 2490 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336779&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324985 384988906 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663705 CC(C)Oc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-c2ncccn2)c1 InChI=1S/C25H28N4O3/c1-17(2)31-19-11-14-26-23(15-19)32-20-10-9-18(3)29(16-20)25(30)22-8-5-4-7-21(22)24-27-12-6-13-28-24/h4-8,11-15,17-18,20H,9-10,16H2,1-3H3/t18-,20-/m1/s1 PFWJKBXMJQXBJD-UYAOXDASSA-N 336780 2-(2-{[(2R,5R)-2-Methyl-5-{[4-(1-methylethoxy)pyridin-2-yl]oxy}piperidin-1-yl]carbonyl}phenyl)pyrimidine::US9745284, 44 Orexin receptor type 2 Homo sapiens 67.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336780 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336780&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78325002 384988907 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663706 CC(C)Oc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-c2ncccn2)c1 InChI=1S/C25H28N4O3/c1-17(2)31-19-11-14-26-23(15-19)32-20-10-9-18(3)29(16-20)25(30)22-8-5-4-7-21(22)24-27-12-6-13-28-24/h4-8,11-15,17-18,20H,9-10,16H2,1-3H3/t18-,20-/m1/s1 PFWJKBXMJQXBJD-UYAOXDASSA-N 336780 2-(2-{[(2R,5R)-2-Methyl-5-{[4-(1-methylethoxy)pyridin-2-yl]oxy}piperidin-1-yl]carbonyl}phenyl)pyrimidine::US9745284, 44 Orexin/Hypocretin receptor type 1 Homo sapiens 1637 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336780 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336780&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78325002 384988907 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663707 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C24H24F2N4O3/c1-16-7-8-18(33-22-13-17(9-12-27-22)32-15-21(25)26)14-30(16)24(31)20-6-3-2-5-19(20)23-28-10-4-11-29-23/h2-6,9-13,16,18,21H,7-8,14-15H2,1H3/t16-,18-/m1/s1 OGUABBYQKDOWFM-SJLPKXTDSA-N 336781 2-(2-{[(2R,5R)-5-{[4-(2,2- difluoroethoxy)pyridin-2- yl]oxy}-2- methylpiperidin-1- yl]carbonyl}phenyl) pyrimidine::US9745284, 45 Orexin receptor type 2 Homo sapiens 33.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336781 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336781&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324986 384988908 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663708 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C24H24F2N4O3/c1-16-7-8-18(33-22-13-17(9-12-27-22)32-15-21(25)26)14-30(16)24(31)20-6-3-2-5-19(20)23-28-10-4-11-29-23/h2-6,9-13,16,18,21H,7-8,14-15H2,1H3/t16-,18-/m1/s1 OGUABBYQKDOWFM-SJLPKXTDSA-N 336781 2-(2-{[(2R,5R)-5-{[4-(2,2- difluoroethoxy)pyridin-2- yl]oxy}-2- methylpiperidin-1- yl]carbonyl}phenyl) pyrimidine::US9745284, 45 Orexin/Hypocretin receptor type 1 Homo sapiens 2944 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336781 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336781&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324986 384988908 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663709 C[C@@H]1CC[C@H](CN1C(=O)c1ccc(F)cc1-c1ncccn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C24H23F3N4O3/c1-15-3-5-18(34-22-12-17(7-10-28-22)33-14-21(26)27)13-31(15)24(32)19-6-4-16(25)11-20(19)23-29-8-2-9-30-23/h2,4,6-12,15,18,21H,3,5,13-14H2,1H3/t15-,18-/m1/s1 OHLOBXOCXKVNBB-CRAIPNDOSA-N 336782 2-(2-{[(2R,5R)-5-{[4-(2,2- difluoroethoxy)pyridin-2- yl]oxy}-2- methylpiperidin-1- yl]carbonyl}-5- fluorophenyl)pyrimidine::US9745284, 46 Orexin receptor type 2 Homo sapiens 63.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336782 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336782&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78325011 384988909 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663710 C[C@@H]1CC[C@H](CN1C(=O)c1ccc(F)cc1-c1ncccn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C24H23F3N4O3/c1-15-3-5-18(34-22-12-17(7-10-28-22)33-14-21(26)27)13-31(15)24(32)19-6-4-16(25)11-20(19)23-29-8-2-9-30-23/h2,4,6-12,15,18,21H,3,5,13-14H2,1H3/t15-,18-/m1/s1 OHLOBXOCXKVNBB-CRAIPNDOSA-N 336782 2-(2-{[(2R,5R)-5-{[4-(2,2- difluoroethoxy)pyridin-2- yl]oxy}-2- methylpiperidin-1- yl]carbonyl}-5- fluorophenyl)pyrimidine::US9745284, 46 Orexin/Hypocretin receptor type 1 Homo sapiens 3522 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336782 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336782&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78325011 384988909 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663711 C[C@@H]1CC[C@H](CN1C(=O)c1ncccc1-c1ncccn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C23H23F2N5O3/c1-15-5-6-17(33-20-12-16(7-11-26-20)32-14-19(24)25)13-30(15)23(31)21-18(4-2-8-27-21)22-28-9-3-10-29-22/h2-4,7-12,15,17,19H,5-6,13-14H2,1H3/t15-,17-/m1/s1 AOUSVPJXAWSLEF-NVXWUHKLSA-N 336783 2-(2-{[(2R,5R)-5-{[4-(2,2- difluoroethoxy)pyridin-2- yl]oxy}-2- methylpiperidin-1- yl]carbonyl}pyridin-3- yl)pyrimidine::US9745284, 47 Orexin receptor type 2 Homo sapiens 84.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336783&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78325012 384988910 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663712 C[C@@H]1CC[C@H](CN1C(=O)c1ncccc1-c1ncccn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C23H23F2N5O3/c1-15-5-6-17(33-20-12-16(7-11-26-20)32-14-19(24)25)13-30(15)23(31)21-18(4-2-8-27-21)22-28-9-3-10-29-22/h2-4,7-12,15,17,19H,5-6,13-14H2,1H3/t15-,17-/m1/s1 AOUSVPJXAWSLEF-NVXWUHKLSA-N 336783 2-(2-{[(2R,5R)-5-{[4-(2,2- difluoroethoxy)pyridin-2- yl]oxy}-2- methylpiperidin-1- yl]carbonyl}pyridin-3- yl)pyrimidine::US9745284, 47 Orexin/Hypocretin receptor type 1 Homo sapiens 9272 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336783&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78325012 384988910 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663713 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)c1C InChI=1S/C22H25N5O3/c1-15-8-9-17(30-21-16(2)20(29-3)10-11-23-21)14-26(15)22(28)18-6-4-5-7-19(18)27-24-12-13-25-27/h4-7,10-13,15,17H,8-9,14H2,1-3H3/t15-,17-/m1/s1 YREPASGUTMHKJX-NVXWUHKLSA-N 336784 4-Methoxy-3-methyl-2-{[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]oxy}pyridine::US9745284, 48 Orexin receptor type 2 Homo sapiens 9.70 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336784 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336784&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324997 384988911 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663714 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)c1C InChI=1S/C22H25N5O3/c1-15-8-9-17(30-21-16(2)20(29-3)10-11-23-21)14-26(15)22(28)18-6-4-5-7-19(18)27-24-12-13-25-27/h4-7,10-13,15,17H,8-9,14H2,1-3H3/t15-,17-/m1/s1 YREPASGUTMHKJX-NVXWUHKLSA-N 336784 4-Methoxy-3-methyl-2-{[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]oxy}pyridine::US9745284, 48 Orexin/Hypocretin receptor type 1 Homo sapiens 568 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336784 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336784&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324997 384988911 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663715 COc1cc(OC)nc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)c1 InChI=1S/C22H25N5O4/c1-15-8-9-16(31-21-13-17(29-2)12-20(25-21)30-3)14-26(15)22(28)18-6-4-5-7-19(18)27-23-10-11-24-27/h4-7,10-13,15-16H,8-9,14H2,1-3H3/t15-,16-/m1/s1 MQRFEOYYAKWIDK-HZPDHXFCSA-N 336785 2,4-Dimethoxy-6-{[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]oxy}pyridine::US9745284, 49 Orexin receptor type 2 Homo sapiens 71.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336785&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324970 384988912 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663716 COc1cc(OC)nc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)c1 InChI=1S/C22H25N5O4/c1-15-8-9-16(31-21-13-17(29-2)12-20(25-21)30-3)14-26(15)22(28)18-6-4-5-7-19(18)27-23-10-11-24-27/h4-7,10-13,15-16H,8-9,14H2,1-3H3/t15-,16-/m1/s1 MQRFEOYYAKWIDK-HZPDHXFCSA-N 336785 2,4-Dimethoxy-6-{[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]oxy}pyridine::US9745284, 49 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336785&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324970 384988912 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663717 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)c1C=O InChI=1S/C22H23N5O4/c1-15-7-8-16(31-21-18(14-28)20(30-2)9-10-23-21)13-26(15)22(29)17-5-3-4-6-19(17)27-24-11-12-25-27/h3-6,9-12,14-16H,7-8,13H2,1-2H3/t15-,16-/m1/s1 SFLYXQMHTBQRLE-HZPDHXFCSA-N 336786 4-Methoxy-2-{[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]oxy}pyridine-3-carbaldehyde::US9745284, 50 Orexin receptor type 2 Homo sapiens 37.5 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336786 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336786&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324984 384988913 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663718 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)c1C=O InChI=1S/C22H23N5O4/c1-15-7-8-16(31-21-18(14-28)20(30-2)9-10-23-21)13-26(15)22(29)17-5-3-4-6-19(17)27-24-11-12-25-27/h3-6,9-12,14-16H,7-8,13H2,1-2H3/t15-,16-/m1/s1 SFLYXQMHTBQRLE-HZPDHXFCSA-N 336786 4-Methoxy-2-{[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]oxy}pyridine-3-carbaldehyde::US9745284, 50 Orexin/Hypocretin receptor type 1 Homo sapiens 6747 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336786 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336786&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324984 384988913 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663719 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)c1C(C)=O InChI=1S/C23H25N5O4/c1-15-8-9-17(32-22-21(16(2)29)20(31-3)10-11-24-22)14-27(15)23(30)18-6-4-5-7-19(18)28-25-12-13-26-28/h4-7,10-13,15,17H,8-9,14H2,1-3H3/t15-,17-/m1/s1 DGAOPKUYPKCBLB-NVXWUHKLSA-N 336787 1-(4-methoxy-2- {[(3R,6R)-6- methyl-1-{[2-(2H- 1,2,3-triazol-2- yl)phenyl]carbonyl} piperidin-3- yl]oxy}pyridin- 3-yl)ethanone::US9745284, 51 Orexin receptor type 2 Homo sapiens 12.3 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336787 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336787&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118659187 384988914 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663720 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccccc2-n2nccn2)c1C(C)=O InChI=1S/C23H25N5O4/c1-15-8-9-17(32-22-21(16(2)29)20(31-3)10-11-24-22)14-27(15)23(30)18-6-4-5-7-19(18)28-25-12-13-26-28/h4-7,10-13,15,17H,8-9,14H2,1-3H3/t15-,17-/m1/s1 DGAOPKUYPKCBLB-NVXWUHKLSA-N 336787 1-(4-methoxy-2- {[(3R,6R)-6- methyl-1-{[2-(2H- 1,2,3-triazol-2- yl)phenyl]carbonyl} piperidin-3- yl]oxy}pyridin- 3-yl)ethanone::US9745284, 51 Orexin/Hypocretin receptor type 1 Homo sapiens 976 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336787 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336787&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118659187 384988914 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663721 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1cc(OC(F)F)ccn1 InChI=1S/C21H21F2N5O3/c1-14-6-7-16(30-19-12-15(8-9-24-19)31-21(22)23)13-27(14)20(29)17-4-2-3-5-18(17)28-25-10-11-26-28/h2-5,8-12,14,16,21H,6-7,13H2,1H3/t14-,16-/m1/s1 JEDFQJSABUAJCH-GDBMZVCRSA-N 336788 (2-(2H-1,2,3-Triazol-2-yl)phenyl)((2R,5R)-5-((4-(difluoromethoxy)pyridin-2-yl)oxy)-2-methylpiperidin-1-yl)methanone::US9745284, 52 Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336788&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 77846099 384988915 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663722 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1cc(OC(F)F)ccn1 InChI=1S/C21H21F2N5O3/c1-14-6-7-16(30-19-12-15(8-9-24-19)31-21(22)23)13-27(14)20(29)17-4-2-3-5-18(17)28-25-10-11-26-28/h2-5,8-12,14,16,21H,6-7,13H2,1H3/t14-,16-/m1/s1 JEDFQJSABUAJCH-GDBMZVCRSA-N 336788 (2-(2H-1,2,3-Triazol-2-yl)phenyl)((2R,5R)-5-((4-(difluoromethoxy)pyridin-2-yl)oxy)-2-methylpiperidin-1-yl)methanone::US9745284, 52 Orexin/Hypocretin receptor type 1 Homo sapiens 194 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336788&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 77846099 384988915 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663723 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1cc(OCF)ccn1 InChI=1S/C21H22FN5O3/c1-15-6-7-17(30-20-12-16(29-14-22)8-9-23-20)13-26(15)21(28)18-4-2-3-5-19(18)27-24-10-11-25-27/h2-5,8-12,15,17H,6-7,13-14H2,1H3/t15-,17-/m1/s1 QQRMCUBCWZJSDQ-NVXWUHKLSA-N 336789 (2-(2H-1,2,3-Triazol-2-yl)phenyl)((2R,5R)-5-((4-(fluoromethoxy)pyridin-2-yl)oxy)-2-methylpiperidin-1-yl)methanone::US9745284, 53 Orexin receptor type 2 Homo sapiens 8.00 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336789&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324972 384988916 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663724 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1cc(OCF)ccn1 InChI=1S/C21H22FN5O3/c1-15-6-7-17(30-20-12-16(29-14-22)8-9-23-20)13-26(15)21(28)18-4-2-3-5-19(18)27-24-10-11-25-27/h2-5,8-12,15,17H,6-7,13-14H2,1H3/t15-,17-/m1/s1 QQRMCUBCWZJSDQ-NVXWUHKLSA-N 336789 (2-(2H-1,2,3-Triazol-2-yl)phenyl)((2R,5R)-5-((4-(fluoromethoxy)pyridin-2-yl)oxy)-2-methylpiperidin-1-yl)methanone::US9745284, 53 Orexin/Hypocretin receptor type 1 Homo sapiens 490 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336789&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324972 384988916 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663725 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)Oc1cc(OC(F)F)ccn1 InChI=1S/C19H19F2N5O3S/c1-12-2-3-14(28-16-10-13(4-6-22-16)29-19(20)21)11-25(12)17(27)15-5-9-30-18(15)26-23-7-8-24-26/h4-10,12,14,19H,2-3,11H2,1H3/t12-,14-/m1/s1 FGSFIGMGVNHWBN-TZMCWYRMSA-N 336790 (2-(2H-1,2,3-Triazol-2-yl)thiophen-3-yl)((2R,5R)-5-((4-(difluoromethoxy)pyridin-2-yl)oxy)-2-methylpiperidin-1-yl)methanone::US9745284, 54 Orexin receptor type 2 Homo sapiens 11.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336790 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336790&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324971 384988917 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663726 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)Oc1cc(OC(F)F)ccn1 InChI=1S/C19H19F2N5O3S/c1-12-2-3-14(28-16-10-13(4-6-22-16)29-19(20)21)11-25(12)17(27)15-5-9-30-18(15)26-23-7-8-24-26/h4-10,12,14,19H,2-3,11H2,1H3/t12-,14-/m1/s1 FGSFIGMGVNHWBN-TZMCWYRMSA-N 336790 (2-(2H-1,2,3-Triazol-2-yl)thiophen-3-yl)((2R,5R)-5-((4-(difluoromethoxy)pyridin-2-yl)oxy)-2-methylpiperidin-1-yl)methanone::US9745284, 54 Orexin/Hypocretin receptor type 1 Homo sapiens 1018 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336790 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336790&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324971 384988917 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663727 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-n1nccn1)Oc1cc(OC(F)F)ccn1 InChI=1S/C19H19F2N5O3S/c1-12-2-3-14(28-17-8-13(4-5-22-17)29-19(20)21)9-25(12)18(27)15-10-30-11-16(15)26-23-6-7-24-26/h4-8,10-12,14,19H,2-3,9H2,1H3/t12-,14-/m1/s1 CLCUVQHMSAJFFH-TZMCWYRMSA-N 336791 4-(difluoromethoxy)- 2-{[(3R,6R)- 6-methyl-1- {[4-(2H-1,2,3- triazol-2-yl) thiophen-3- yl]carbonyl} piperidin- 3-yl]oxy}pyridine::US9745284, 55 Orexin receptor type 2 Homo sapiens 13.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336791 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336791&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78324973 384988918 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663728 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-n1nccn1)Oc1cc(OC(F)F)ccn1 InChI=1S/C19H19F2N5O3S/c1-12-2-3-14(28-17-8-13(4-5-22-17)29-19(20)21)9-25(12)18(27)15-10-30-11-16(15)26-23-6-7-24-26/h4-8,10-12,14,19H,2-3,9H2,1H3/t12-,14-/m1/s1 CLCUVQHMSAJFFH-TZMCWYRMSA-N 336791 4-(difluoromethoxy)- 2-{[(3R,6R)- 6-methyl-1- {[4-(2H-1,2,3- triazol-2-yl) thiophen-3- yl]carbonyl} piperidin- 3-yl]oxy}pyridine::US9745284, 55 Orexin/Hypocretin receptor type 1 Homo sapiens 1760 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336791 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336791&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78324973 384988918 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663729 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)Oc1cc(OC(F)F)ccn1 InChI=1S/C23H23F2N3O3/c1-15-6-7-17(30-20-12-16(8-11-27-20)31-22(24)25)13-28(15)21(29)18-4-2-3-5-19(18)23(14-26)9-10-23/h2-5,8,11-12,15,17,22H,6-7,9-10,13H2,1H3/t15-,17-/m1/s1 XGCOWCPOPSXVDV-NVXWUHKLSA-N 336792 1-(2-{[(2R,5R)- 5-{[4- (difluoromethoxy) pyridin-2-yl]oxy}-2- methylpiperidin-1- yl]carbonyl}phenyl) cyclopropane- carbonitrile::US9745284, 56 Orexin receptor type 2 Homo sapiens 11.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336792 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336792&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 90389581 384988919 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663730 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)Oc1cc(OC(F)F)ccn1 InChI=1S/C23H23F2N3O3/c1-15-6-7-17(30-20-12-16(8-11-27-20)31-22(24)25)13-28(15)21(29)18-4-2-3-5-19(18)23(14-26)9-10-23/h2-5,8,11-12,15,17,22H,6-7,9-10,13H2,1H3/t15-,17-/m1/s1 XGCOWCPOPSXVDV-NVXWUHKLSA-N 336792 1-(2-{[(2R,5R)- 5-{[4- (difluoromethoxy) pyridin-2-yl]oxy}-2- methylpiperidin-1- yl]carbonyl}phenyl) cyclopropane- carbonitrile::US9745284, 56 Orexin/Hypocretin receptor type 1 Homo sapiens 1145 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336792 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336792&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 90389581 384988919 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663731 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)Oc1cc(OC(F)F)ccn1 InChI=1S/C20H20F2N6O3/c1-13-6-7-15(30-18-10-14(8-9-23-18)31-20(21)22)11-27(13)19(29)16-4-2-3-5-17(16)28-25-12-24-26-28/h2-5,8-10,12-13,15,20H,6-7,11H2,1H3/t13-,15-/m1/s1 SSGUVMGJJQAZAS-UKRRQHHQSA-N 336793 4-(difluoromethoxy)- 2-{[(3R,6R)-6- methyl-1-{[2-(2H- tetrazol-2-yl)phenyl] carbonyl}piperidin- 3-yl]oxy}pyridine::US9745284, 57 Orexin receptor type 2 Homo sapiens 11.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336793&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78325014 384988920 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663732 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)Oc1cc(OC(F)F)ccn1 InChI=1S/C20H20F2N6O3/c1-13-6-7-15(30-18-10-14(8-9-23-18)31-20(21)22)11-27(13)19(29)16-4-2-3-5-17(16)28-25-12-24-26-28/h2-5,8-10,12-13,15,20H,6-7,11H2,1H3/t13-,15-/m1/s1 SSGUVMGJJQAZAS-UKRRQHHQSA-N 336793 4-(difluoromethoxy)- 2-{[(3R,6R)-6- methyl-1-{[2-(2H- tetrazol-2-yl)phenyl] carbonyl}piperidin- 3-yl]oxy}pyridine::US9745284, 57 Orexin/Hypocretin receptor type 1 Homo sapiens 1690 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336793&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78325014 384988920 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663733 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccsc2-c2ncccn2)c1 InChI=1S/C21H22N4O3S/c1-14-4-5-16(28-18-12-15(27-2)6-10-22-18)13-25(14)21(26)17-7-11-29-19(17)20-23-8-3-9-24-20/h3,6-12,14,16H,4-5,13H2,1-2H3/t14-,16-/m1/s1 IHDPOVVYCVYVSA-GDBMZVCRSA-N 336794 ((2R,5R)-5-((4-Methoxypyridin-2-yl)oxy)-2-methylpiperidin-1-yl)(2-(pyrimidin-2-yl)thiophen-3-yl)methanone::US9745284, 58 Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336794 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336794&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78325046 384988921 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663734 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccsc2-c2ncccn2)c1 InChI=1S/C21H22N4O3S/c1-14-4-5-16(28-18-12-15(27-2)6-10-22-18)13-25(14)21(26)17-7-11-29-19(17)20-23-8-3-9-24-20/h3,6-12,14,16H,4-5,13H2,1-2H3/t14-,16-/m1/s1 IHDPOVVYCVYVSA-GDBMZVCRSA-N 336794 ((2R,5R)-5-((4-Methoxypyridin-2-yl)oxy)-2-methylpiperidin-1-yl)(2-(pyrimidin-2-yl)thiophen-3-yl)methanone::US9745284, 58 Orexin/Hypocretin receptor type 1 Homo sapiens 1107 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336794 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336794&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78325046 384988921 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663735 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccsc2-n2nccn2)c1 InChI=1S/C19H21N5O3S/c1-13-3-4-15(27-17-11-14(26-2)5-7-20-17)12-23(13)18(25)16-6-10-28-19(16)24-21-8-9-22-24/h5-11,13,15H,3-4,12H2,1-2H3/t13-,15-/m1/s1 BKAWVYDEXMFBBR-UKRRQHHQSA-N 336795 4-methoxy-2- {[(3R,6R)-6-methyl-1- {[2-(2H-1,2,3-triazol- 2-yl)thiophen-3- yl]carbonyl}piperidin- 3-yl]oxy}pyridine::US9745284, 59 Orexin receptor type 2 Homo sapiens 11.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336795 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336795&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78325013 384988922 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663736 COc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccsc2-n2nccn2)c1 InChI=1S/C19H21N5O3S/c1-13-3-4-15(27-17-11-14(26-2)5-7-20-17)12-23(13)18(25)16-6-10-28-19(16)24-21-8-9-22-24/h5-11,13,15H,3-4,12H2,1-2H3/t13-,15-/m1/s1 BKAWVYDEXMFBBR-UKRRQHHQSA-N 336795 4-methoxy-2- {[(3R,6R)-6-methyl-1- {[2-(2H-1,2,3-triazol- 2-yl)thiophen-3- yl]carbonyl}piperidin- 3-yl]oxy}pyridine::US9745284, 59 Orexin/Hypocretin receptor type 1 Homo sapiens 1264 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336795 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336795&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78325013 384988922 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663737 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C20H21F2N5O3S/c1-13-2-3-15(30-18-10-14(4-6-23-18)29-12-17(21)22)11-26(13)19(28)16-5-9-31-20(16)27-24-7-8-25-27/h4-10,13,15,17H,2-3,11-12H2,1H3/t13-,15-/m1/s1 IKHHGRGIFQXBFV-UKRRQHHQSA-N 336796 (2-(2H-1,2,3-Triazol-2-yl)thiophen-3-yl)((2R,5R)-5-((4-(2,2-difluoroethoxy)pyridin-2-yl)oxy)-2-methylpiperidin-1-yl)methanone::US9745284, 60 Orexin receptor type 2 Homo sapiens 22.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336796&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78325031 384988923 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663738 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C20H21F2N5O3S/c1-13-2-3-15(30-18-10-14(4-6-23-18)29-12-17(21)22)11-26(13)19(28)16-5-9-31-20(16)27-24-7-8-25-27/h4-10,13,15,17H,2-3,11-12H2,1H3/t13-,15-/m1/s1 IKHHGRGIFQXBFV-UKRRQHHQSA-N 336796 (2-(2H-1,2,3-Triazol-2-yl)thiophen-3-yl)((2R,5R)-5-((4-(2,2-difluoroethoxy)pyridin-2-yl)oxy)-2-methylpiperidin-1-yl)methanone::US9745284, 60 Orexin/Hypocretin receptor type 1 Homo sapiens 2017 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336796&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78325031 384988923 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663739 CC(C)Oc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccsc2-n2nccn2)c1 InChI=1S/C21H25N5O3S/c1-14(2)28-16-6-8-22-19(12-16)29-17-5-4-15(3)25(13-17)20(27)18-7-11-30-21(18)26-23-9-10-24-26/h6-12,14-15,17H,4-5,13H2,1-3H3/t15-,17-/m1/s1 CXZYDJCFSCODJJ-NVXWUHKLSA-N 336797 4-(1-methylethoxy)-2- {[(3R,6R)-6-methyl-1-{[2- (2H-1,2,3-triazol- 2-yl)thiophen-3- yl]carbonyl}piperidin- 3-yl]oxy}pyridine::US9745284, 61 Orexin receptor type 2 Homo sapiens 25.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336797 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336797&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78325060 384988924 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663740 CC(C)Oc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccsc2-n2nccn2)c1 InChI=1S/C21H25N5O3S/c1-14(2)28-16-6-8-22-19(12-16)29-17-5-4-15(3)25(13-17)20(27)18-7-11-30-21(18)26-23-9-10-24-26/h6-12,14-15,17H,4-5,13H2,1-3H3/t15-,17-/m1/s1 CXZYDJCFSCODJJ-NVXWUHKLSA-N 336797 4-(1-methylethoxy)-2- {[(3R,6R)-6-methyl-1-{[2- (2H-1,2,3-triazol- 2-yl)thiophen-3- yl]carbonyl}piperidin- 3-yl]oxy}pyridine::US9745284, 61 Orexin/Hypocretin receptor type 1 Homo sapiens 1479 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336797 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336797&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78325060 384988924 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663741 CCOc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccsc2-n2nccn2)c1 InChI=1S/C20H23N5O3S/c1-3-27-15-6-8-21-18(12-15)28-16-5-4-14(2)24(13-16)19(26)17-7-11-29-20(17)25-22-9-10-23-25/h6-12,14,16H,3-5,13H2,1-2H3/t14-,16-/m1/s1 UJLQKWJTXFUAPI-GDBMZVCRSA-N 336798 4-ethoxy-2-{[(3R,6R)-6- methyl-1-{[2-(2H-1,2,3- triazol-2-yl)thiophen-3- yl]carbonyl}piperidin-3- yl]oxy}pyridine::US9745284, 62 Orexin receptor type 2 Homo sapiens 22.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336798 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336798&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78325033 384988925 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663742 CCOc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccsc2-n2nccn2)c1 InChI=1S/C20H23N5O3S/c1-3-27-15-6-8-21-18(12-15)28-16-5-4-14(2)24(13-16)19(26)17-7-11-29-20(17)25-22-9-10-23-25/h6-12,14,16H,3-5,13H2,1-2H3/t14-,16-/m1/s1 UJLQKWJTXFUAPI-GDBMZVCRSA-N 336798 4-ethoxy-2-{[(3R,6R)-6- methyl-1-{[2-(2H-1,2,3- triazol-2-yl)thiophen-3- yl]carbonyl}piperidin-3- yl]oxy}pyridine::US9745284, 62 Orexin/Hypocretin receptor type 1 Homo sapiens 1162 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336798 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336798&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78325033 384988925 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663743 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)Oc1cc(OCC(F)(F)F)ccn1 InChI=1S/C20H20F3N5O3S/c1-13-2-3-15(31-17-10-14(4-6-24-17)30-12-20(21,22)23)11-27(13)18(29)16-5-9-32-19(16)28-25-7-8-26-28/h4-10,13,15H,2-3,11-12H2,1H3/t13-,15-/m1/s1 AMYVAZAFHPSJDZ-UKRRQHHQSA-N 336799 2-{[(3R,6R)-6-methyl-1- {[2-(2H-1,2,3-triazol-2- yl)thiophen-3-yl]carbonyl} piperidin-3-yl]oxy}-4- (2,2,2-trifluoroethoxy) pyridine::US9745284, 63 Orexin receptor type 2 Homo sapiens 55.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336799&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78325034 384988926 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663744 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)Oc1cc(OCC(F)(F)F)ccn1 InChI=1S/C20H20F3N5O3S/c1-13-2-3-15(31-17-10-14(4-6-24-17)30-12-20(21,22)23)11-27(13)18(29)16-5-9-32-19(16)28-25-7-8-26-28/h4-10,13,15H,2-3,11-12H2,1H3/t13-,15-/m1/s1 AMYVAZAFHPSJDZ-UKRRQHHQSA-N 336799 2-{[(3R,6R)-6-methyl-1- {[2-(2H-1,2,3-triazol-2- yl)thiophen-3-yl]carbonyl} piperidin-3-yl]oxy}-4- (2,2,2-trifluoroethoxy) pyridine::US9745284, 63 Orexin/Hypocretin receptor type 1 Homo sapiens 8381 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336799&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78325034 384988926 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663745 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1ncccn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C22H22F2N4O3S/c1-14-3-4-16(31-19-11-15(5-9-25-19)30-13-18(23)24)12-28(14)22(29)17-6-10-32-20(17)21-26-7-2-8-27-21/h2,5-11,14,16,18H,3-4,12-13H2,1H3/t14-,16-/m1/s1 SSOLHLIZGQHOBQ-GDBMZVCRSA-N 336800 ((2R,5R)-5-((4-(2,2-Difluoroethoxy)pyridin-2-yl)oxy)-2-methylpiperidin-1-yl)(2-(pyrimidin-2-yl)thiophen-3-yl)methanone::US9745284, 64 Orexin receptor type 2 Homo sapiens 36.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336800 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336800&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78325030 384988927 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663746 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1ncccn1)Oc1cc(OCC(F)F)ccn1 InChI=1S/C22H22F2N4O3S/c1-14-3-4-16(31-19-11-15(5-9-25-19)30-13-18(23)24)12-28(14)22(29)17-6-10-32-20(17)21-26-7-2-8-27-21/h2,5-11,14,16,18H,3-4,12-13H2,1H3/t14-,16-/m1/s1 SSOLHLIZGQHOBQ-GDBMZVCRSA-N 336800 ((2R,5R)-5-((4-(2,2-Difluoroethoxy)pyridin-2-yl)oxy)-2-methylpiperidin-1-yl)(2-(pyrimidin-2-yl)thiophen-3-yl)methanone::US9745284, 64 Orexin/Hypocretin receptor type 1 Homo sapiens 5214 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336800 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336800&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78325030 384988927 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663747 CCOc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccsc2-c2ncccn2)c1 InChI=1S/C22H24N4O3S/c1-3-28-16-7-11-23-19(13-16)29-17-6-5-15(2)26(14-17)22(27)18-8-12-30-20(18)21-24-9-4-10-25-21/h4,7-13,15,17H,3,5-6,14H2,1-2H3/t15-,17-/m1/s1 SECXUNCFVQIWHB-NVXWUHKLSA-N 336801 ((2R,5R)-5-(4-Ethoxypyridin-2-yloxy)-2-methylpiperidin-1-yl)(2-(pyrimidin-2-yl)thiophen-3-yl)methanone::US9745284, 65 Orexin receptor type 2 Homo sapiens 26.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336801&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78325015 384988928 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663748 CCOc1ccnc(O[C@@H]2CC[C@@H](C)N(C2)C(=O)c2ccsc2-c2ncccn2)c1 InChI=1S/C22H24N4O3S/c1-3-28-16-7-11-23-19(13-16)29-17-6-5-15(2)26(14-17)22(27)18-8-12-30-20(18)21-24-9-4-10-25-21/h4,7-13,15,17H,3,5-6,14H2,1-2H3/t15-,17-/m1/s1 SECXUNCFVQIWHB-NVXWUHKLSA-N 336801 ((2R,5R)-5-(4-Ethoxypyridin-2-yloxy)-2-methylpiperidin-1-yl)(2-(pyrimidin-2-yl)thiophen-3-yl)methanone::US9745284, 65 Orexin/Hypocretin receptor type 1 Homo sapiens 899 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336801&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78325015 384988928 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 663749 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1ncccn1)Oc1cc(OCC(F)(F)F)ccn1 InChI=1S/C22H21F3N4O3S/c1-14-3-4-16(32-18-11-15(5-9-26-18)31-13-22(23,24)25)12-29(14)21(30)17-6-10-33-19(17)20-27-7-2-8-28-20/h2,5-11,14,16H,3-4,12-13H2,1H3/t14-,16-/m1/s1 IEQMJGHQJXJPJI-GDBMZVCRSA-N 336802 2-(3-{[(2R,5R)-2- methyl-5-{[4-(2,2,2- trifluoroethoxy) pyridin-2-yl]oxy} piperidin-1-yl] carbonyl}thiophen 2-yl)pyrimidine::US9745284, 66 Orexin receptor type 2 Homo sapiens 26.0 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336802 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336802&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 78325032 384988929 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 663750 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1ncccn1)Oc1cc(OCC(F)(F)F)ccn1 InChI=1S/C22H21F3N4O3S/c1-14-3-4-16(32-18-11-15(5-9-26-18)31-13-22(23,24)25)12-29(14)21(30)17-6-10-33-19(17)20-27-7-2-8-28-20/h2,5-11,14,16H,3-4,12-13H2,1H3/t14-,16-/m1/s1 IEQMJGHQJXJPJI-GDBMZVCRSA-N 336802 2-(3-{[(2R,5R)-2- methyl-5-{[4-(2,2,2- trifluoroethoxy) pyridin-2-yl]oxy} piperidin-1-yl] carbonyl}thiophen 2-yl)pyrimidine::US9745284, 66 Orexin/Hypocretin receptor type 1 Homo sapiens 2080 US Patent 10.7270/Q2X92DD6 aid1797058 US9745284 Kuduk, SD; Skudlarek, JW 8/29/2017 7/5/2019 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=336802 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=336802&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 78325032 384988929 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6